Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 3, 2004, Pages 862-870

  Demaria, Sandra ^a   Ng, Bruce ^a   Devitt, Mary Louise ^a   Babb, James S ^a   Kawashima, Noriko ^a   Liebes, Leonard ^a   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antitumor immunity; Breast cancer; Dendritic cells; Flt3 Ligand; Ionizing radiation

Indexed keywords

CELLS; IONIZING RADIATION; RADIOTHERAPY; TUMORS;

INFLAMMATORY SIGNALS; TUMOR GROWTH;

ONCOLOGY;

FLT3 LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CELL ACTIVATION; DENDRITIC CELL; FEMALE; IMMUNITY; INFLAMMATION; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; T LYMPHOCYTE; TUMOR; TUMOR IMMUNITY;

EID: 1242315588     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.012     Document Type: Article

References (59)

1. Melief C.J.M. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res. 58:1992;143-175.
2. Schuler G., Schuler-Thurner B., Steinman R.M. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol. 15:2003;138-147.
3. Chen L., Ashe S., Brady W.A., et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1992;1093-1102.
4. + T cells by B7-transfected melanoma cells. Science. 259:1993;368-370.
5. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med. 143:1976;1283-1288.
6. Huang A., Golumbek P., Ahmadzadeh M., et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:1994;961-965.
7. Fonteneau J.F., Larsson M., Bhardwaj N. Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses. Curr Opin Immunol. 14:2002;471-477.
8. Sauter B., Albert M.L., Francisco L., et al. Consequences of cell death Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells . J Exp Med. 191:2000;423-433.
9. Mellman I., Steinman R.M. Dendritic cells Specialized and regulated antigen processing machines . Cell. 106:2001;255-258.
10. Watters D. Molecular mechanisms of ionizing radiation-induced apoptosis. Immunol Cell Biol. 77:1999;263-271.
11. Hong J.H., Chiang C.S., Campbell I.L., et al. Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys. 33:1995;619-626.
12. Hong J.H., Chiang C.S., Tsao C.Y., et al. Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol. 75:1999;1421-1427.
13. Quarmby S., Kumar P., Kumar S. Radiation-induced normal tissue injury Role of adhesion molecules in leukocyte-endothelial cell interactions . Int J Cancer. 82:1999;385-395.
14. Steinauer K.K., Gibbs I., Ning S., et al. Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. Int J Radiat Oncol Biol Phys. 48:2000;325-328.
15. Nikitina E.Y., Gabrilovich D.I. Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice Approach to treatment of advanced stage cancer . Int J Cancer. 94:2001;825-833.
16. Ganss R., Ryschich E., Klar E., et al. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res. 62:2002;1462-1470.
17. Nobler M.P. The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology. 93:1969;410-412.
18. Ehlers G., Fridman M. Abscopal effect of radiation in papillary adenocarcinoma. Br J Radiol. 46:1973;220-222.
19. Kingsley D.P. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol. 48:1975;863-866.
20. Antoniades J., Brady L.W., Lightfoot D.A. Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int J Radiat Oncol Biol Phys. 2:1977;141-147.
21. Rees G.J. Abscopal regression in lymphoma A mechanism in common with total body irradation? Clin Radiol. 32:1981;475-480.
22. Sham R.L. The abscopal effect and chronic lymphocytic leukemia. Am J Med. 98:1995;307-308.
23. Ohba K., Omagari K., Nakamura T., et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut. 43:1998;575-577.
24. Mole R.J. Whole body irradiation - radiology or medicine? Br J Radiol. 26:1953;234-241.
25. Uchida A., Mizutani Y., Nagamuta M., et al. Effects of X-ray irradiation on natural killer (NK) cell system. I. Elevation of sensitivity of tumor cells and lytic function of NK cells. Immunopharmacol Immunotoxicol. 11:1989;507-519.
26. Macklis R.M., Mauch P.M., Burakoff S.J., et al. Lymphoid irradiation results in long-term increases in natural killer cells in patients treated for Hodgkin's disease. Cancer. 69:1992;778-783.
27. Kusmartsev S., Gabrilovich D.I. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother. 51:2002;293-298.
28. Awwad M., North R.J. Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors. Cancer Res. 50:1990;2228-2233.
29. Cameron R.B., Spiess P.J., Rosenberg S.A. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action. J Exp Med. 171:1990;249-263.
30. Dybal E.J., Haas G.P., Maughan R.L., et al. Synergy of radiation therapy and immunotherapy in murine renal cell carcinoma. J Urol. 148:1992;1331-1337.
31. Younes E., Haas G.P., Dezso B., et al. Radiation-induced effects on murine kidney tumor cells Role in the interaction of local irradiation and immunotherapy . J Urol. 153:1995;2029-2033.
32. Chiang C.S., Syljuasen R.G., Hong J.H., et al. Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo. Cancer Res. 57:1997;3899-3903.
33. Maraskovsky E., Brasel K., Teepe M., et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice Multiple dendritic cell subpopulations identified . J Exp Med. 184:1996;1953-1962.
34. Lynch D.H., Andreasen A., Maraskovsky E., et al. Flt3 ligand induces tumor regression and anti-tumor immune responses in vivo. Nat Med. 3:1997;625-631.
35. Chakravarty P.K., Alfieri A., Thomas E.K., et al. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res. 59:1999;6028-6032.
36. Al-Sarraf M., LeBlanc M., Giri P.G., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer Phase III randomized Intergroup study 0099 . J Clin Oncol. 16:1998;1310-1317.
37. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 17:1999;2692-2699.
38. National Cancer Institute. Concurrent chemo-radiation for cervical cancer. Clinical announcement. Washington DC; 1999.
39. Formenti S.C., Cohen D., Tsao-Wei D.D., et al. Clinical course of locally advanced breast cancer (LABC) patients with pathological response to primary concurrent 5-fluorouracil and radiation (FU/RT). Int J Radiat Oncol Biol Phys. 51:2001;195-196.
40. Aslakson C.J., Miller F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52:1992;1399-1405.
41. Kim K.J., Kanellopoulos-Langevin C., Merwin R.M., et al. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol. 122:1979;549-554.
42. Lutz M.B., Kukutsch N., Ogilvie A.L.J., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 223:1999;77-92.
43. Camphausen K., Moses M.A., Menard C., et al. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 63:2003;1990-1993.
44. Chen L., McGowan P., Ashe S., et al. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med. 179:1994;523-532.
45. Martin-Fontecha A., Cavallo F., Bellone M., et al. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors. Eur J Immunol. 26:1996;1851-1859.
46. Chiang C.S., McBride W.H. Radiation enhances tumor necrosis factor alpha production by murine brain cells. Brain Res. 566:1991;265-269.
47. Van Der Meeren A., Squiban C., Gourmelon P., et al. Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine. 11:1999;831-838.
48. Heckelsmiller K., Rall K., Beck S., et al. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model. J Immunol. 169:2002;3892-3899.
49. Hashimoto W., Tanaka F., Robbins P.D., et al. Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18. Int J Cancer. 103:2003;508-513.
50. Jung S., Unutmaz D., Wong P., et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity. 17:2002;211-220.
51. Gabrilovich D.I., Chen H.L., Girgis K.R., et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med. 2:1996;1096-1103.
52. Gabrilovich D.I., Corak J., Ciernik I.F., et al. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res. 3:1997;483-490.
53. Gabrilovich D.I., Velders M.P., Sotomayor E.M., et al. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol. 166:2001;5398-5406.
54. Melani C, Chiodoni C, Forni G, et al. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 2003;May 15; [epub ahead of print].
55. Almand B., Clark J., Nikitina E.Y., et al. Increased production of immature myeloid cells in cancer patients as a mechanism of immunosuppression in cancer. J Immunol. 166:2001;678-689.
56. Almand B., Resser J., Lindman B., et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res. 6:2000;1755-1766.
57. Bronte V., Chappell D.B., Apolloni E., et al. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J Immunol. 162:1999;5728-5737.
58. Pulendran B., Banchereau J., Burkeholder S., et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol. 165:2000;566-572.
59. Dallal R.M., Lotze M.T. The dendritic cell and human cancer vaccines. Curr Opin Immunol. 12:2000;583-588.